Financial Daily from THE HINDU group of publications
Monday, Aug 01, 2005
Financial Daily from THE HINDU group of publications Monday, Aug 01, 2005 |
|
|
|
|
|
|
|
Corporate
-
Announcements Ranbaxy gets tentative FDA nod for diabetes drug Our Bureau
New Delhi , July 31 RANBAXY Laboratories Ltd has received tentative approval from the US Food and Drug Administration to manufacture and market glimepiride tablets, 3 mg and 6 mg used for treatment of diabetes. The total annual market sales for Aventis Pharmaceuticals' Amaryl tablets were $336.6 million. Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with non-insulin-dependent (Type II) diabetes mellitus whose hyperglycemia cannot be controlled by diet and exercise alone, according to Mr Jim Meehan, Vice-President of Sales and Marketing for Ranbaxy Pharmaceuticals Inc.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|